LogicBio Therapeutics LOGC
$ 6.65
-1.19%
Quarterly report 2022-Q3
added 11-14-2022
LogicBio Therapeutics Cash and Cash Equivalents 2011-2024 | LOGC
Annual Cash and Cash Equivalents LogicBio Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
53.5 M | 70.1 M | 33.1 M | 80.9 M | 24.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
80.9 M | 24.6 M | 52.4 M |
Quarterly Cash and Cash Equivalents LogicBio Therapeutics
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 30.8 M | 38.8 M | 42.7 M | 53.5 M | 59.6 M | 68.1 M | 63.9 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 33.1 M | 33.1 M | 33.1 M | 33.1 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 24.6 M | 24.6 M | - | - | 1.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
80.9 M | 1.73 M | 52 M |